Title Collection Author Date
Tech Week: Do We Really Need Femtech? Special Report Leah Hodgson 22/09/22
Who’s Made Bank on BioNTech? Equity Research & Insights Sunniva Kolostyak 09/12/21
3 Biotech Stock Picks Investment Trust Research & Insights Holly Black 07/07/21
Biotech Beyond Covid Investment Trust Research & Insights Holly Black 17/06/21
Big Pharma, Big Returns? Equity Research & Insights James Gard 15/03/21
3 Biotech Stock Picks Fund Research & Insights Holly Black 02/10/19
What is Biotech Investing? Investment Trust Research & Insights Holly Black 26/09/19
Ignore Politics, Innovation is Driving Healthcare Stocks Fund Research & Insights James Gard 24/09/19
Alternative Assets Offer Opportunities Investment Trust Research & Insights Holly Black 20/06/19
How to Tap Into the Genetics Revolution Perspectives EdenTree 29/03/19
Investor Views: My Funds Have Done Better Than Stocks ISA Investing Emma Simon 07/03/19
Liontrust: 3 ESG Stock Picks Equity Research & Insights David Brenchley 23/01/19
5 Best and Worst Top-Rated Trusts in Q3 Investment Trust Research & Insights David Brenchley 04/10/18
Henderson Backs Two Tech Alternative Trusts Investment Trust Research & Insights David Brenchley 25/09/18
ETF Investors Look to Healthcare Stocks ETF Research & Insights David Brenchley 13/09/18
GlaxoSmithKline Shares Still Undervalued Equity Research & Insights Damien Conover 31/07/18
Investor Views: "My Biotech Funds are Up 400%" Investment Trust Research & Insights Emma Simon 25/07/18
Woodford-Backed Prothena Loses 70% Equity Research & Insights David Brenchley 24/04/18
Will the Budget Boost Woodford's Performance? Investment Trust Research & Insights David Brenchley 01/12/17
3 Alternative Strategies for Your Portfolio Investment Trust Research & Insights Emma Wall 27/07/17
Investor Views: "I’m Sticking with Biotech Stocks – Despite 50% Falls" ISA Investing Emma Simon 21/06/17
Top 10 Investment Trusts in May Investment Trust Research & Insights Karen Kwok 12/06/17
Biotech Trusts Trade at Discount Investment Trust Research & Insights Karen Kwok 26/05/17
Are Healthcare Stocks Too Expensive? Equity Research & Insights Dan Kemp 02/05/17
Will Trump’s Policies Provide a Boost or Brake on Healthcare Funds? Fund Research & Insights Sam Shaw 07/02/17
UK Pharma Stocks Fall as Trump Repeals Obamacare Equity Research & Insights Karen Kwok 02/02/17
Pharma Stocks Remain Undervalued Despite Clinton Loss Equity Research & Insights Karen Kwok 29/11/16
Healthcare and Mining Stocks Gain On Trump Win Equity Research & Insights Karen Kwok 09/11/16
Why Healthcare Stocks Will be the Real Winner of the US Election Equity Research & Insights Karen Kwok 26/09/16
Fund Managers Attempt to Thwart EU Ban on Past Performance Data Fund Research & Insights Emma Simon 20/06/16
5 US Stocks with a Wide Stable Moat Equity Research & Insights Karen Kwok 23/02/16
Is the Rally Over for Biotech Funds? Fund Research & Insights Karen Kwok 21/01/16
Page   1 of 1
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures